NCT02570919View on ClinicalTrials.gov

Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 1, 2015

Primary Completion Date

September 30, 2017

Study Completion Date

December 31, 2017

Conditions
PROSTATE CANCER
Interventions
RADIATION

IGRT 45 Gy in 5 fractions of 9 Gy

Administration of 9 Gy in five consecutive days, to a total dose of 45 Gy radiation

RADIATION

IGRT 24 Gy single dose

Administration of a single dose of 24 Gy in one session

Trial Locations (1)

1400-038

Champalimaud Foundation, Lisbon

All Listed Sponsors
lead

Fundacao Champalimaud

OTHER

NCT02570919 - Phase II Study of Ultra-high-dose Hypofractionated vs. Single-dose Image-Guided Radiotherapy for Prostate Cancer | Biotech Hunter | Biotech Hunter